FTRE (Fortrea Holdings Inc.) Short-Term Debt to Capital

Corporate company logo of Fortrea Holdings Inc. (FTRE)

Fortrea Holdings Inc. (FTRE) possesses limited pricing power, while its competitive advantage lies in conducting global early-stage drug trials. The business relies on an extensive network of global centers and immense experience in implementing medical innovations. This price chart on GURU.Markets shows the value of the 0.09 metric, and long-term agreements with biotech firms sustain demand despite partial saturation of the US market.

Ratio of Short-Term Indebtedness to Capital: Fortrea Corp (FTRE) for 02/21/2024 - 11/01/2026

Analytical breakdowns for Fortrea Holdings Inc.

- stock quotes and analyst forecast:
Stock Price Fortrea Corp|FTRE - Fair Value Consensus
- business market valuation indicators:
Market Capitalization Fortrea Holdings Inc|FTRE - Enterprise Value
- book capitalization information:
Net Assets per Single Share Fortrea|FTRE - Accounting Value of Company|Market Value to Book Value Ratio fortrea.com|FTRE - Cumulative Company Assets
- company liabilities and liquidity data:
Total Debt to Capital Fortrea Holdings Inc.|FTRE - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Fortrea|FTRE - Aggregate Debt Obligations|Debt to Book Value Fortrea Holdings Inc|FTRE - Amount of Long-Term Liabilities|Company Short-Term Debts Fortrea|Quick Liquidity fortrea.com
- company profitability and valuation multiples indicators:
FTRE - Net Financial Result
Fundamental valuation:Fortrea Corp FTRE
Brand item of Fortrea Holdings Inc

This indicator measures the degree of equity dependence on liabilities maturing within one year, allowing for an assessment of liquidity risks amid changes in borrowing costs. By analyzing the ratio of current loans to equity, an investor can gauge the financial stability of Fortrea Holdings Inc. (FTRE), whose reputation as a premium partner in clinical research ensures access to stable financing even under a high debt load.

Key competitors

Short-Term Debt to Capital IQV|LH (LabCorp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital MEDP (Medpace Holdings, Inc.)|Short-Term Debt to Capital ICON Corp ICLR|CRL - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EVO (Evotec AG)|lifecore.com (LFCR) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio OmniAb Inc|NOTV (Inotiv, Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital avidbio.com|Short-Term Debt to Equity Ratio CTLT (Catalent)|SCPX (Scorpius Holdings Inc.) - Ratio of Short-Term Indebtedness to Capital